You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Donor specific Antibody

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Cytomegalovirus, Donor Trial in Columbus (Allogeneic

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
  • +3 more
  • Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes
  • Columbus, Ohio
  • +1 more
Apr 20, 2022

Multiple Myeloma Trial in New York (drug, biological, procedure)

Active, not recruiting
  • Multiple Myeloma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023

Kidney Transplant Rejection Trial in Los Angeles (Extended-release tacrolimus, Immediate-release tacrolimus)

Recruiting
  • Kidney Transplant Rejection
  • Extended-release tacrolimus
  • Immediate-release tacrolimus
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jan 18, 2022

MDS, Acute Myeloid Leukemia With Myelodysplasia Related Disease and < 30% Blasts, Mixed Myelodysplastic/Myeloproliferative

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Stockholm, Sweden
    Department of Hematology, Karolinska University Hospital
Mar 27, 2023

Liver Transplant Trial in Boston (biological, procedure, drug)

Recruiting
  • Liver Transplant
  • arTreg-CSB
  • +4 more
  • Boston, Massachusetts
    Massachusetts General Hospital: Transplantation
Jan 30, 2023

Minimal Residual Disease, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Adult Acute Myeloid

Completed
  • Minimal Residual Disease
  • +3 more
  • Daratumumab
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 2, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (MultiTAA-specific T cells)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • MultiTAA-specific T cells
  • Houston, Texas
  • +1 more
May 31, 2022

Antibody-mediated Rejection, Allosensitization Trial in New York (Isatuximab, bone marrow biopsy)

Not yet recruiting
  • Antibody-mediated Rejection
  • Allosensitization
  • New York, New York
    NYU Langone Health
May 16, 2023

Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

Not yet recruiting
  • Relapsed/Refractory Chronic Lymphocytic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Jul 13, 2023

COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,

Suspended
  • COVID-19 Infection
  • +2 more
  • Questionnaire Administration
  • Sotrovimab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 24, 2023

Hematologic Malignancies Trial in Shanghai (GNC-035)

Recruiting
  • Hematologic Malignancies
  • Guiyang, Guizhou, China
  • +3 more
Jan 13, 2023

SPAD in Adult Patients

Not yet recruiting
  • Specific Antibody Deficiency
  • Predominantly Antibody Deficiencies
  • Diagnosis of SPAD using immunization with PPV23
  • (no location specified)
Dec 15, 2022

Allogeneic Stell Cell Transplant, Viral Infection Trial in Cincinnati (Viral Specific T-cells (VSTs) Scheduled, Viral Specific

Recruiting
  • Allogeneic Stell Cell Transplant
  • Viral Infection
  • Viral Specific T-cells (VSTs) Scheduled
  • Viral Specific T-cells (VSTs) Treatment
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Mar 17, 2022

Hematological Malignancies, CMV Infection Trial in Belgium (CMV-specific T cells, Standard anti-viral therapy)

Completed
  • Hematological Malignancies
  • CMV Infection
  • CMV-specific T cells
  • Standard anti-viral therapy
  • Gent, Oost-Vlaanderen, Belgium
  • +7 more
Dec 19, 2022

Aging Frailty Trial in United States (Longeveron Mesenchymal Stem Cells (LMSCs), Fluzone High Dose Vaccine)

Completed
  • Aging Frailty
  • Longeveron Mesenchymal Stem Cells (LMSCs)
  • Fluzone High Dose Vaccine
  • Coral Gables, Florida
  • +5 more
Nov 3, 2022

Drug Antibody and Precision Transfusion in China

Recruiting
  • Drug-specific Antibodies
    • Guangzhou, Gaungdong, China
      Nanfang hospital of southern medical university
    Nov 2, 2022

    HIV-Infected Individuals Trial in Baltimore (DD HST-NEETs)

    Recruiting
    • HIV-Infected Individuals
    • DD HST-NEETs
    • Baltimore, Maryland
      Johns Hopkins University(Jhu)
    Mar 2, 2022

    Glioma, Solid Tumor Trial in Beijing (GNC-039)

    Recruiting
    • Glioma
    • Solid Tumor
    • Beijing, Beijing, China
    • +5 more
    Jan 12, 2023

    Myasthenia Gravis, MuSK Trial in Cleveland, Philadelphia (Amifampridine Phosphate)

    Active, not recruiting
    • Myasthenia Gravis, MuSK
    • Amifampridine Phosphate
    • Cleveland, Ohio
    • +1 more
    Jul 21, 2022

    Nasopharyngeal Carcinoma, Nasopharyngeal Cancer Trial in China (Cadonilimab, Gemcitabine, Cisplatin)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Nasopharyngeal Cancer
    • Bengbu, Anhui, China
    • +12 more
    Dec 13, 2022

    Adenovirus Infection, EBV, Cytomegalovirus Infections Trial in Basel (IFN-? positive selected T-cells)

    Recruiting
    • Adenovirus Infection
    • +4 more
    • IFN-γ positive selected T-cells
    • Basel, Switzerland
      Universitätsspital Basel
    Apr 11, 2022

    Liver Transplant, Liver Transplantation Trial in United States (Immunosuppression withdrawal)

    Completed
    Has Results
    • Liver Transplant
    • Liver Transplantation
    • Immunosuppression withdrawal
    • San Francisco, California
    • +6 more
    Aug 10, 2022

    Kidney Transplantation, Kidney Transplant Rejection Trial in Guangzhou

    Not yet recruiting
    • Kidney Transplantation
    • Kidney Transplant Rejection
      • Guangzhou, Guangdong, China
        The First Affiliated Hospital, Sun Yat-sen University
      Mar 19, 2023

      Non-hodgkin Lymphoma Trial in Tianjin (GNC-038)

      Recruiting
      • Non-hodgkin Lymphoma
      • Hefei, Anhui, China
      • +9 more
      Jan 12, 2023

      An Observational Antibody Level Study.

      Recruiting
      • Healthy
        • Birmingham, United Kingdom
          NHSBT - Birmingham Donation Centre
        Jul 9, 2021